EMBC

Embecta Corp.

20.59

Top Statistics
Market Cap 1 B Forward PE 8.22 Revenue Growth -4.80 %
Current Ratio 2.11 Trailing PE 15.37 Earnings Growth -3.80 %
Profit Margins 6.23 % Peg Ratio Dividend Yield 4.16 %
Enterprice / EBITA 9.59 Enterprise / Revenue 1.97 Price To Sales Trailing12 Months 1.06
Profitability
Profit Margins 6.23 % Operating Margins 29.98 %
Balance Sheet
Total Cash 275 M Total Cash Per Share 4.77 Total Debt 1 B
Total Debt To Equity Current Ratio 2.11 Book Value Per Share -13.24
All Measures
Short Ratio 631.00 % Message Board Id finmb_714010553 Shares Short Prior Month 1 M
City Parsippany Uuid 8d0a6de8-9472-32e2-99d1-9a4592f958e7 Previous Close 18.70
First Trade Date Epoch Utc 1 B Book Value -13.24 Beta 0.9360
Total Debt 1 B Volume 787602 Fifty Two Week Low 9.93
Total Cash Per Share 4.77 Total Revenue 1 B Shares Short Previous Month Date 1 B
Target Median Price 18.20 Audit Risk 6 Max Age 86400
Recommendation Mean 3.17 Sand P52 Week Change 0.3133 Operating Margins 29.98 %
Last Dividend Value 0.1500 Target Mean Price 17.07 Net Income To Common 69 M
Short Percent Of Float 0.0431 Implied Shares Outstanding 57 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 564700 Average Volume10days 564700
Total Cash 275 M Next Fiscal Year End 1 B Revenue Per Share 19.44
Held Percent Insiders 0.0047 Ebitda Margins 20.59 % Dividend Rate 0.6000
Trailing PE 15.37 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 2 Regular Market Previous Close 18.70 Target Low Price 13.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 14.48 Open 19.47
Dividend Yield 4.16 % State NJ Free Cashflow 46 M
Return On Assets 0.0964 Time Zone Short Name EST Board Risk 2
Trailing Eps 1.34 Day Low 19.11 Address1 300 Kimball Drive
Shares Outstanding 57 M Compensation Risk 2 Price Hint 2
Target High Price 20.00 Website https://www.embecta.com 52 Week Change 0.1227
Average Volume 395684 Earnings Quarterly Growth -3.30 % Forward Eps 2.27
Recommendation Key hold Compensation As Of Epoch Date 1 B Quick Ratio 140.20 %
Is_sp_500 False Regular Market Day High 20.68 Profit Margins 6.23 %
Fifty Two Week High 20.80 Day High 20.68 Shares Short 1 M
Regular Market Open 19.47 Industry Key medical-instruments-supplies Earnings Growth -3.80 %
Enterprise To Revenue 1.97 Revenue Growth -4.80 % Shares Percent Shares Out 0.0307
Operating Cashflow 38 M Currency USD Time Zone Full Name America/New_York
Market Cap 1 B Is_nasdaq_100 False Zip 07054
Payout Ratio 50.00 % Quote Type EQUITY Industry Medical Instruments & Supplies
Ex Dividend Date 1 B Overall Risk 2 Regular Market Day Low 19.11
Held Percent Institutions 0.9823 Long Name Embecta Corp. Address2 Suite 300
Enterprise To Ebitda 9.59 Current Price 20.59 Financial Currency USD
Current Ratio 2.11 Gross Margins 66.42 % Industry Disp Medical Instruments & Supplies
Number Of Analyst Opinions 3 Country United States Float Shares 53 M
Two Hundred Day Average 13.64 Governance Epoch Date 1 B Enterprise Value 2 B
Price To Sales Trailing12 Months 1.06 Forward PE 8.22 Regular Market Volume 787602
Last Dividend Date 1 B Ebitda 230 M Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
Embecta Corp.

, a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.

Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.

The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Embecta Corp.

was founded in 1924 and is headquartered in Parsippany, New Jersey.